about
Abnormal melatonin synthesis in autism spectrum disordersDifferentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biologyGenetics of Paget's disease of boneThe serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.Clinical spectrum and outcomes in families with coronal synostosis and TCF12 mutations.Deletion of serotonin 2B receptor provokes structural alterations of mouse dental tissues.Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient miceOverexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.Decreased osteoclastogenesis in serotonin-deficient mice.Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5Reduced 3-O-methyl-dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele.Large deletions encompassing the TCOF1 and CAMK2A genes are responsible for Treacher Collins syndrome with intellectual disability.Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation.Treacher Collins syndrome: a clinical and molecular study based on a large series of patients.Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblastsCrouzon syndrome and Bent bone dysplasia associated with mutations at the same Tyr-381 residue in FGFR2 gene.Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort.Accuracy of urine NGAL commercial assays in critically ill patients.Enamel alterations in serotonin 2B receptor knockout mice.Imbalanced Angiogenesis in Peripartum Cardiomyopathy - Diagnostic Value of Placenta Growth Factor.A case-control study of fractures in men with idiopathic osteoporosis: fractures are associated with older age and low cortical bone density.Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury.Exchangeable copper: a reflection of the neurological severity in Wilson's disease.Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis.S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study.Y-craniosynostosis by premature fusion of the metopic and coronal sutures: a new nosological entity or a variety of Saethre-Chotzen syndrome?First case of osteopathia striata with cranial sclerosis in an adult male with Klinefelter syndrome.Coronal craniosynostosis and radial ray hypoplasia: a third report of Twist mutation in a 33 weeks fetus with diaphragmatic hernia.Skull base morphology in fibroblast growth factor receptor type 2-related faciocraniosynostosis: a descriptive analysis.The foramen magnum in isolated and syndromic brachycephaly.The growth of the foramen magnum in Crouzon syndrome.A new case of bent bone dysplasia--FGFR2 type and review of the literature.A novel TWIST1 gene mutation in a patient with Saethre-Chotzen syndrome.MSX2 Gene Duplication in a Patient with Eye Development Defects.Autosomal recessive POLR1D mutation with decrease of TCOF1 mRNA is responsible for Treacher Collins syndrome.Germline mutations in FGF receptors and medulloblastomas.Central nervous system malformations and deformations in FGFR2-related craniosynostosis.
P50
Q24652560-DA40157B-E42C-499D-ABD6-DE3036D38AE6Q28303937-D99F54F9-857D-44D9-926B-298017CE4FE3Q28304592-106ADD7B-1874-4847-B5B8-21DFE2F59E74Q33617543-B189BCF8-4B0A-4D05-ACAF-A9C04DE2D0BEQ33642091-8D1DEFB3-557F-4958-901C-81D8C87998FDQ34508300-CD5B7A36-9C3D-4C67-9633-10B37DD1B130Q34661102-92D24A2D-48D8-4422-A51E-8CB96C5C2648Q35164832-F810235B-0891-4AFD-8D40-6CA48D500473Q35757224-129BF1B8-4916-4C44-84BE-72F7529CEE9BQ35787005-3F8EFFD0-F2F1-4D29-A02F-64E65DE5D9C3Q36556223-BF6CFDA9-A75A-49AD-B5D9-899131ACC3ACQ36897022-B43D481B-B5B7-4D3A-8646-56FF0EE960C0Q37397682-6DEE4FB4-AEF6-4B37-975B-C90E09C6849CQ38900984-AE640442-3841-41A5-B4F7-89A918CA14C9Q40204098-243A1442-FBF8-4C3B-99E7-AF4E651C2D1BQ40398226-2DB36D82-A09C-4484-8676-F68C3AED2987Q41192966-E98E744D-4562-4653-8FD2-386C6243A673Q42629276-2DB06B57-0C41-4342-A56D-B0E31FD3DD9CQ43500408-E439314E-8CEE-45DC-89A3-66050759389AQ43724908-E803A2B0-7978-4C91-AEED-A8BD5CB0E267Q44455481-4140A4E0-0171-49B5-AF7C-34BC498BBB4AQ46291773-28797626-C715-46C2-8F73-21257714F7E9Q46852037-7AE5A09D-0C80-4D6E-B353-96F23757F866Q46859211-B226F904-2806-45F1-B2AA-39769E514740Q47848062-083B2F44-04E0-4DD1-8BCD-B6410C485CF7Q48301726-07D82740-A367-49DD-A664-529ED9E2114EQ48697427-191DD78C-F6FC-4D64-9186-EC309061D9EBQ48874738-0DCA742C-EA5A-4E2E-9AA6-370669730840Q50592543-D7DB4C0A-D957-4329-8BC0-040D8937F9E6Q50881090-135B9E27-8F16-428B-80F7-7720416491E6Q51310517-3F61415C-0D1E-49F8-AAFB-A66741D302E8Q53014589-A99EA7BE-11F4-49F8-A8E5-7466903080C0Q53091467-E27AC5F3-D08B-47B1-8572-71A7CB2B6AF7Q53148325-3C55AC92-1F9F-4C9E-82D3-DB65739F7B68Q53276201-D434AA32-18D1-4A5B-82E5-6EBC381F05D7Q53722813-26BADCC2-D004-45E8-B5B4-D1D4FE0DB9F4Q54216373-942D9A06-304B-4E0D-A54C-B6DDD4240209Q54372503-947AEF68-5FD0-46B5-A874-62CBCCAFAE5BQ54456683-3B3824AF-B317-4195-8EF2-3D458C3DE9AEQ54482923-3D18466D-689D-4568-A14F-E3E5DFD09A7C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Corinne Collet
@ast
Corinne Collet
@en
Corinne Collet
@es
Corinne Collet
@nl
Corinne Collet
@sl
type
label
Corinne Collet
@ast
Corinne Collet
@en
Corinne Collet
@es
Corinne Collet
@nl
Corinne Collet
@sl
prefLabel
Corinne Collet
@ast
Corinne Collet
@en
Corinne Collet
@es
Corinne Collet
@nl
Corinne Collet
@sl
P106
P21
P31
P496
0000-0001-6990-863X